Agios Pharmaceuticals Inc (AGIO)
44.82
-0.06
(-0.12%)
USD |
NASDAQ |
Nov 04, 16:00
44.82
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Shareholders Equity (Quarterly): 1.627B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.627B |
June 30, 2024 | 660.51M |
March 31, 2024 | 743.92M |
December 31, 2023 | 811.02M |
September 30, 2023 | 886.84M |
June 30, 2023 | 964.24M |
March 31, 2023 | 1.037B |
December 31, 2022 | 1.101B |
September 30, 2022 | 1.050B |
June 30, 2022 | 1.124B |
March 31, 2022 | 1.207B |
December 31, 2021 | 1.292B |
September 30, 2021 | 1.395B |
June 30, 2021 | 1.722B |
March 31, 2021 | 2.297B |
December 31, 2020 | 399.50M |
September 30, 2020 | 480.45M |
June 30, 2020 | 558.46M |
March 31, 2020 | 625.30M |
December 31, 2019 | 640.53M |
September 30, 2019 | 448.29M |
June 30, 2019 | 532.68M |
March 31, 2019 | 620.26M |
December 31, 2018 | 687.54M |
Date | Value |
---|---|
September 30, 2018 | 760.21M |
June 30, 2018 | 823.14M |
March 31, 2018 | 865.59M |
December 31, 2017 | 375.50M |
September 30, 2017 | 449.81M |
June 30, 2017 | 508.99M |
March 31, 2017 | 307.38M |
December 31, 2016 | 358.59M |
September 30, 2016 | 401.45M |
June 30, 2016 | 289.08M |
March 31, 2016 | 332.37M |
December 31, 2015 | 345.12M |
September 30, 2015 | 375.66M |
June 30, 2015 | 404.16M |
March 31, 2015 | 426.82M |
December 31, 2014 | 424.37M |
September 30, 2014 | 207.75M |
June 30, 2014 | 200.55M |
March 31, 2014 | 121.34M |
December 31, 2013 | 131.48M |
September 30, 2013 | 142.60M |
June 30, 2013 | 28.87M |
March 31, 2013 | 37.12M |
December 31, 2012 | 43.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
399.50M
Minimum
Dec 2020
2.297B
Maximum
Mar 2021
1.031B
Average
1.000B
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 87.70B |
Regeneron Pharmaceuticals Inc | 29.33B |
Ligand Pharmaceuticals Inc | 775.20M |
ADMA Biologics Inc | 188.27M |
AnaptysBio Inc | 9.879M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.792B |
Total Liabilities (Quarterly) | 165.12M |
Current Ratio | 8.993 |